Northwell Health

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

154

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

3 drugs in development

Phase 22

Phase 11

Preclinical1

By Therapeutic Area

top 3

Oncology

250%

Metabolic & Endocrine

125%

Musculoskeletal

125%

R&D Momentum

63/100

Pipeline Velocity

36/100

Trial Completion Rate

51/100

Pipeline Concentration

38/100

Pipeline Freshness

57/100

Strategic Signals

↗Early-stage heavy pipeline may seek late-stage partners
↗Active in Metabolic & Endocrine but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Jul 10, 2026

Enrolling by invitation

WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCT

Jul 9, 2026

Completed

Using the Cholinergic Anit-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain

Earlier

Jun 30, 2026TrialThe Effect of a Multi-Component Behavior Change Technique Intervention on Physical Activity Among Individuals on Primary Prevention Statin Therapy: A Dose-Finding Pilot Study

Jun 27, 2026TrialEarly Treatment ctDNA Dynamics to Predict Response to Chemotherapy in Patients With Advanced Pancreatic Cancer: a Prospective, Observational Pilot Study

Jun 25, 2026TrialPilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

Nov 17, 2025TrialINFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases

Nov 3, 2025TrialFactor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

Nov 1, 2025TrialCerebellum-based Imaging Neural Markers for Antipsychotic Response

2 more events

Oct 1, 2025TrialMobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)

Aug 1, 2025TrialImpact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

FX006Phase 2

Musculoskeletal

Bursitis

FX006Phase 2

Osteoarthritis

FX006Phase 2

Oncology

Breast Cancer

Intra-arterial MannitolPhase 1

Glioblastoma

Intra-arterial MannitolPhase 2

Pancreatic Cancer

Gemcitabine plus nab-paclitaxelPreclinical

Pancreatic Ductal Adenocarcinoma

Gemcitabine plus nab-paclitaxelPhase 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)